Michael Yee
Stock Analyst at Jefferies
(2.69)
# 1,912
Out of 4,829 analysts
82
Total ratings
41.07%
Success rate
5.67%
Average return
Main Sectors:
Stocks Rated by Michael Yee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BPMC Blueprint Medicines | Initiates: Buy | $135 | $97.17 | +38.93% | 1 | Mar 17, 2025 | |
| ALXO ALX Oncology Holdings | Upgrades: Buy | $2 → $3 | $0.42 | +610.40% | 5 | Mar 6, 2025 | |
| CRGX CARGO Therapeutics | Downgrades: Hold | $32 → $3 | $4.03 | -25.47% | 3 | Jan 30, 2025 | |
| KOD Kodiak Sciences | Upgrades: Buy | $20 | $3.77 | +430.50% | 3 | Dec 9, 2024 | |
| BIIB Biogen | Downgrades: Hold | $250 → $180 | $118.17 | +52.32% | 5 | Dec 9, 2024 | |
| VRTX Vertex Pharmaceuticals | Upgrades: Buy | $500 → $550 | $424.99 | +29.41% | 4 | Dec 9, 2024 | |
| AMGN Amgen | Maintains: Buy | $380 | $265.86 | +42.93% | 5 | Nov 12, 2024 | |
| DNLI Denali Therapeutics | Maintains: Buy | $40 → $45 | $14.37 | +213.15% | 2 | Nov 1, 2024 | |
| MRNA Moderna | Maintains: Hold | $65 → $55 | $24.25 | +126.80% | 8 | Oct 15, 2024 | |
| MBX MBX Biosciences | Initiates: Buy | $35 | $11.11 | +215.03% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $9.54 | +319.29% | 1 | Sep 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $385 | $684.59 | -43.76% | 4 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $1.4 → $10 | $2.09 | +378.47% | 3 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $16 → $3 | $1.14 | +163.16% | 2 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $75 → $30 | $17.41 | +72.31% | 2 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $60 → $20 | $10.38 | +92.68% | 8 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $8 → $20 | $30.67 | -34.79% | 3 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $63 → $75 | $4.48 | +1,574.11% | 1 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $1.24 | +2,319.35% | 1 | Nov 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $65 | $28.40 | +128.87% | 1 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $75 → $45 | $0.31 | +14,510.39% | 2 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $40 → $30 | $0.80 | +3,658.46% | 4 | Feb 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $15 → $30 | $7.43 | +303.77% | 3 | Feb 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $120 | $12.24 | +880.39% | 2 | Nov 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $70 → $75 | $23.91 | +213.68% | 2 | Oct 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $11.18 | +168.46% | 1 | Sep 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $77 | $10.38 | +641.81% | 2 | Nov 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $96.91 | - | 3 | Jan 26, 2018 |
Blueprint Medicines
Mar 17, 2025
Initiates: Buy
Price Target: $135
Current: $97.17
Upside: +38.93%
ALX Oncology Holdings
Mar 6, 2025
Upgrades: Buy
Price Target: $2 → $3
Current: $0.42
Upside: +610.40%
CARGO Therapeutics
Jan 30, 2025
Downgrades: Hold
Price Target: $32 → $3
Current: $4.03
Upside: -25.47%
Kodiak Sciences
Dec 9, 2024
Upgrades: Buy
Price Target: $20
Current: $3.77
Upside: +430.50%
Biogen
Dec 9, 2024
Downgrades: Hold
Price Target: $250 → $180
Current: $118.17
Upside: +52.32%
Vertex Pharmaceuticals
Dec 9, 2024
Upgrades: Buy
Price Target: $500 → $550
Current: $424.99
Upside: +29.41%
Amgen
Nov 12, 2024
Maintains: Buy
Price Target: $380
Current: $265.86
Upside: +42.93%
Denali Therapeutics
Nov 1, 2024
Maintains: Buy
Price Target: $40 → $45
Current: $14.37
Upside: +213.15%
Moderna
Oct 15, 2024
Maintains: Hold
Price Target: $65 → $55
Current: $24.25
Upside: +126.80%
MBX Biosciences
Oct 8, 2024
Initiates: Buy
Price Target: $35
Current: $11.11
Upside: +215.03%
Sep 13, 2024
Initiates: Buy
Price Target: $40
Current: $9.54
Upside: +319.29%
Jul 17, 2024
Initiates: Buy
Price Target: $385
Current: $684.59
Upside: -43.76%
Mar 27, 2024
Upgrades: Buy
Price Target: $1.4 → $10
Current: $2.09
Upside: +378.47%
Mar 15, 2024
Downgrades: Hold
Price Target: $16 → $3
Current: $1.14
Upside: +163.16%
Dec 8, 2023
Downgrades: Hold
Price Target: $75 → $30
Current: $17.41
Upside: +72.31%
Oct 25, 2023
Downgrades: Hold
Price Target: $60 → $20
Current: $10.38
Upside: +92.68%
Oct 25, 2023
Upgrades: Buy
Price Target: $8 → $20
Current: $30.67
Upside: -34.79%
Jan 6, 2023
Upgrades: Buy
Price Target: $63 → $75
Current: $4.48
Upside: +1,574.11%
Nov 15, 2021
Initiates: Buy
Price Target: $30
Current: $1.24
Upside: +2,319.35%
Mar 2, 2021
Initiates: Buy
Price Target: $65
Current: $28.40
Upside: +128.87%
Mar 2, 2021
Downgrades: Hold
Price Target: $75 → $45
Current: $0.31
Upside: +14,510.39%
Feb 12, 2021
Downgrades: Hold
Price Target: $40 → $30
Current: $0.80
Upside: +3,658.46%
Feb 12, 2021
Upgrades: Buy
Price Target: $15 → $30
Current: $7.43
Upside: +303.77%
Nov 6, 2020
Downgrades: Hold
Price Target: $120
Current: $12.24
Upside: +880.39%
Oct 12, 2020
Upgrades: Buy
Price Target: $70 → $75
Current: $23.91
Upside: +213.68%
Sep 14, 2020
Initiates: Buy
Price Target: $30
Current: $11.18
Upside: +168.46%
Nov 8, 2018
Assumes: Buy
Price Target: $77
Current: $10.38
Upside: +641.81%
Jan 26, 2018
Upgrades: Buy
Price Target: n/a
Current: $96.91
Upside: -